ANTA Biotech builds compact, automated biotechnology platforms that can run biological assays in extreme environments such as space, polar ice, deep‑sea sites, or remote field stations.
Funding
Funding not disclosed
Founders
Product
Problem
Researchers conducting biological experiments in extreme environments such as space, polar regions, deep‑sea locations, or remote field sites face the logistical challenge of transporting samples back to central laboratories for analysis, which is costly, time‑consuming, and often impractical.
Solution
ANTA Biotech creates automated, miniaturized biotechnology platforms that operate independently of gravity and harsh environmental conditions. These devices perform on‑site biological assays and process data locally, delivering results in real time without the need to return physical samples. By integrating edge computing capabilities, the platforms transmit processed data rather than raw specimens, enabling immediate scientific insight and decision‑making. The technology is designed for deployment on spacecraft, remote research stations, and field laboratories, expanding the reach of biological research to previously inaccessible locations.
Target Audience
Primary customers are scientific research organizations, space agencies, and field laboratories that need reliable, on‑site biological testing capabilities in remote or extreme environments.
Features
- Compact, gravity‑agnostic hardware that can function in microgravity, extreme cold, high pressure, and other harsh conditions
- Fully automated assay workflows requiring minimal user intervention
- On‑device data processing and analysis (edge computing) with secure transmission of results to central servers
- Modular design allowing customization for a variety of biochemical and molecular biology protocols
- Robust environmental sealing and power management for extended operation in remote or off‑grid settings